Delivery Order SPE2DB22D1017-SPE2DB25FG8GL
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The $2,770.74 contract has a performance period through January 29, 2024 and does not utilize any set-aside designations. This delivery order is issued under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,265.90 delivery order on July 18, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls, with completion scheduled for July 21, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a completion date of February 8, 2024 and a potential value of $2,770.74. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a potential value of $3,869.37 and a completion date of January 26, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, with a ceiling value of $3,021.20. This firm fixed-price delivery order is non-set-aside and represents a single transaction under the company's broader pharmaceutical supply framework with DLA. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of July 23, 2025. This...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a Firm Fixed Price delivery order contract (SPE2DX15D2205|SPE2DX24F79BR) by the Defense Logistics Agency (DLA) Troop Support Medical to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals. The contract has a ceiling value of $12,873.09 and a performance period ending on March 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,770.89 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,098.96 to AmerisourceBergen Drug Corp's Corporate Office Division on May 20, 2024. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical products, with a ceiling value of $20,552.85. This firm fixed price, non-set-aside delivery order is scheduled for completion by July 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the federal medical...
- This is a $22,165.92 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The contract has an ultimate completion date of July 30, 2024 and is not set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...